Folate receptor type beta is a neutrophilic lineage marker and is differentially expressed in myeloid leukemia. - Wikidata - wikimedia - TriplyDB

Folate receptor type beta is a neutrophilic lineage marker and is differentially expressed in myeloid leukemia.

Folate receptor type beta is a neutrophilic lineage marker and is differentially expressed in myeloid leukemia.

http://www.wikidata.org/entity/Q33852399

about

Folate receptor-β constitutes a marker for human proinflammatory monocytes Targeted drug delivery via folate receptors in recurrent ovarian cancer: a review Structures of human folate receptors reveal biological trafficking states and diversity in folate and antifolate recognition 'Acute myeloid leukemia: a comprehensive review and 2016 update'Complete mapping of divergent amino acids responsible for differential ligand binding of folate receptors alpha and beta.Selective expression of folate receptor beta and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis.Classification of ex vivo methotrexate resistance in acute lymphoblastic and myeloid leukaemia.Insight into nanoparticle cellular uptake and intracellular targeting Folate-targeted imaging of activated macrophages in rats with adjuvant-induced arthritis.Mechanisms of membrane transport of folates into cells and across epithelia.Targeting human clonogenic acute myelogenous leukemia cells via folate conjugated liposomes combined with receptor modulation by all-trans retinoic acid.The ABCs of membrane transporters in health and disease (SLC series): introduction.Folate and thiamine transporters mediated by facilitative carriers (SLC19A1-3 and SLC46A1) and folate receptors.Rheumatoid arthritis and tumor necrosis factor alpha.Folic acid-tethered Pep-1 peptide-conjugated liposomal nanocarrier for enhanced intracellular drug delivery to cancer cells: conformational characterization and in vitro cellular uptake evaluation.Membrane transporters and folate homeostasis: intestinal absorption and transport into systemic compartments and tissues.Pharmacogenetics and folate metabolism -- a promising direction.mRNA instability in the nucleus due to a novel open reading frame element is a major determinant of the narrow tissue specificity of folate receptor alpha.Receptor induction and targeted drug delivery: a new antileukaemia strategy.Resistance to antifolates.Targeting of folate receptor β on acute myeloid leukemia blasts with chimeric antigen receptor-expressing T cells Folic acid inhibits COLO-205 colon cancer cell proliferation through activating the FRα/c-SRC/ERK1/2/NFκB/TP53 pathway: in vitro and in vivo studies.Folate Receptor-Beta Has Limited Value for Fluorescent Imaging in Ovarian, Breast and Colorectal Cancer Assessment of folate receptor-β expression in human neoplastic tissues.Targeted Proteomics Enables Simultaneous Quantification of Folate Receptor Isoforms and Potential Isoform-based Diagnosis in Breast Cancer.Novel Therapy for Atherosclerosis Using Recombinant Immunotoxin Against Folate Receptor β-Expressing Macrophages High-affinity FRβ-specific CAR T cells eradicate AML and normal myeloid lineage without HSC toxicity.Prospects in folate receptor-targeted radionuclide therapy Preparation, characterization and pharmacokinetics of folate receptor-targeted liposomes for docetaxel delivery.Regulation of folate receptor 1 gene expression in the visceral endoderm.Enhanced receptor-mediated endocytosis and cytotoxicity of a folic acid-desacetylvinblastine monohydrazide conjugate in a pemetrexed-resistant cell line lacking folate-specific facilitative carriers but with increased folate receptor expression Clinical translation of folate receptor-targeted therapeutics.Targeted drug delivery to macrophages.In vivo optical imaging of folate receptor-β in head and neck squamous cell carcinoma.Modular nanotransporters for targeted intracellular delivery of drugs: folate receptors as potential targets.Folate Receptor β Regulates Integrin CD11b/CD18 Adhesion of a Macrophage Subset to Collagen.Uptake of etoposide in CT-26 cells of colorectal cancer using folate targeted dextran stearate polymeric micelles.Folate Receptor-Targeted Diagnostics and Therapeutics for Inflammatory Diseases.Evaluation of specific delivery of chimeric phi29 pRNA/siRNA nanoparticles to multiple tumor cells.Smart Human-Serum-Albumin-As2 O3 Nanodrug with Self-Amplified Folate Receptor-Targeting Ability for Chronic Myeloid Leukemia Treatment.

P2860

Q24300693-728733B2-DF87-41CA-9A91-D909C7EDCF3A Q26828581-5CA9FA7D-DE95-49BA-999C-171248BB3A04 Q27679502-9DD3CAF9-31DC-4B48-9168-D61FA3CC2A4D Q28072539-C2608781-C836-4A24-8326-28772075B95E Q33858155-0E2AB99A-0447-4DF9-8C69-8F5263F19E86 Q33870942-D1619A9D-3ADD-41CE-B6B6-533F5378E0D6 Q34071693-44CF5542-F06D-4088-A003-CD6EAAB196B7 Q34127625-9FB030DB-E81F-4131-9FFA-5305ACE469E3 Q34139674-229FB4DD-96A1-4639-A580-DAED03F4D3B5 Q34184787-214E9B5F-BA2B-4DA7-9086-E21577DCC2FE Q34316154-3D344663-7959-4F6C-9652-3A175FD37590 Q34333686-77663D32-0400-4D02-957C-7C6B6BB28F5D Q34333704-A6231DAC-0190-4861-B4BE-1B3DEE2E1A53 Q34572250-D7001F98-B935-4324-A6D7-414BCAD237A8 Q34628862-55DD773A-A1DC-4368-A84A-5513ACD0BA2F Q34658009-5F716581-8D31-43B2-B6F7-3CE5414AF42A Q34673321-7FFA9ADE-6C60-4CE6-AE43-98F272204677 Q34741148-0724D55D-36FA-4073-AD8F-B4504C4EAAFB Q35164785-F7B1F77A-8975-4A14-974D-8A65153C1AF4 Q35567272-93099983-33A7-4605-A880-747FB42B2C27 Q35661999-2A989C14-BFBD-4CC0-A48E-074CAB59C214 Q35701974-DDE0BFA5-B4B2-466D-8C6B-C3524AB007F6 Q35738875-1569674C-53CB-4AE2-A297-1FCA795DA42A Q35987448-11846646-034F-41B1-978B-D1B036383EF4 Q36287593-330AB65F-984E-41ED-840B-8AFE880D2F73 Q36366225-1420B2DA-7D09-4FAC-BB30-ABA5DAD0379C Q36957716-F79E325A-7EDA-4FF2-9FD9-F5E1BF1248ED Q37193061-E1B6AF79-40C6-4888-A4DB-7BA6C02A5095 Q37251547-4DE7B255-85AF-4EC8-8BF1-B7EE6592EE30 Q37317345-B66C3665-0CC0-49CA-A1E1-C9B79671BDE5 Q37553497-E907C2C9-7940-4173-A496-D6B34C47D96A Q38015901-65BB0952-0792-44E6-A375-C1859B29E703 Q38071672-AC503815-6252-460B-B040-5044929B3BAD Q38180615-107174C4-EC42-4A08-8844-CA3B3F815581 Q38259956-46F0375F-CA0E-4B50-81BC-1F89469F4315 Q38830402-255E97CF-2854-42F5-A401-AD8C73525526 Q39009550-19B26AF5-9534-4E00-94F1-B5C189EE05FD Q39062717-06B687FA-3F06-41C2-9BFF-DC9BE5D8BB88 Q39788190-BE9A2F97-6C23-4C00-AEB8-D5A016D29259 Q40144113-79931166-9C09-495B-967E-7692A2825D48

P2860

Folate receptor type beta is a neutrophilic lineage marker and is differentially expressed in myeloid leukemia.

http://www.wikidata.org/entity/Q33852399

description

1999 nî lūn-bûn

@nan

1999 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Folate receptor type beta is a ...... expressed in myeloid leukemia.

@ast

Folate receptor type beta is a ...... expressed in myeloid leukemia.

@en

type

label

Folate receptor type beta is a ...... expressed in myeloid leukemia.

@ast

Folate receptor type beta is a ...... expressed in myeloid leukemia.

@en

prefLabel

Folate receptor type beta is a ...... expressed in myeloid leukemia.

@ast

Folate receptor type beta is a ...... expressed in myeloid leukemia.

@en

P1433

Q33852399-9772B30E-511D-4E2A-9D42-88CBFFFC1444

P1476

Q33852399-B2BE7C5B-7DC9-4374-ABCC-F7CBC0944E38

P2093

Q33852399-0AE16949-47FE-4AE5-A379-FAC07D86EB49

Q33852399-1EB13227-2CD6-46CD-80A6-F94DFFA66573

Q33852399-8ED3E9B0-4CB8-42A6-B406-32355D0F61FE

Q33852399-9072B0FA-AE04-48C6-A782-4595FA95784E

Q33852399-C45A5C0F-C0CE-45F4-A4D1-90C673DCA1B9

Q33852399-C8B6A448-DD45-4354-A69A-EB37C855B135

Q33852399-D4FE9F6B-FD2C-4489-B627-AA74699422E5

P2860

Q33852399-1162C436-13ED-48B4-A7A7-61DA7BB14671

Q33852399-1AD58778-D302-4D06-B4F1-0D1B97BAA8E5

Q33852399-4E610914-8589-4D8C-BCE5-EB17E46EFDD4

Q33852399-663E8C0D-E7F4-497C-88A2-A76C9B72ECD3

Q33852399-7CC6D027-9990-4EDB-B159-A57E6A89D41F

Q33852399-8D299438-C69A-421C-925F-C25D4FAE1FED

Q33852399-AF90DCB4-C130-4680-BF4D-F1A33C5BB135

Q33852399-B3FEF9F1-1DC9-449C-AC0E-63DBC4FB55CE

Q33852399-DE54A7F5-EF94-4649-BBA1-BFC347F7C0A1

Q33852399-E158221B-A6F1-4463-A152-845C14780462

P304

Q33852399-6051317E-A21D-465B-8623-6C6A0F4C7626

P31

Q33852399-357ABABC-968F-4670-9ECC-3459C578132A

P356

Q33852399-88EB7420-AD56-4349-BA06-8FAAA70D9702

P407

Q33852399-1DF271C5-5DDF-46DD-A10C-855949DA2C85

P433

Q33852399-37BCF677-FDB3-44FC-8F09-7D42F25C7B4A

P478

Q33852399-83E6C50A-4760-4582-A8E8-9BF5BF76AFAE

P577

Q33852399-24D2418F-5FE9-4689-AB18-B2646A8B86D4

P698

Q33852399-AB9AEFC7-1A2A-4EA3-8077-C7DD62E9388B

P921

Q33852399-30A21B3B-E679-4E06-84C8-1D64D577BEE2

P356

(SICI)1097-0142(19990115)85:2%3C348::AID-CNCR12%3E3.0.CO;2-4

P1433

P1476

Folate receptor type beta is a ...... expressed in myeloid leukemia.

@en

P2093

Behm FG

http://www.w3.org/2001/XMLSchema#string

Booth R

http://www.w3.org/2001/XMLSchema#string

Mathew P

http://www.w3.org/2001/XMLSchema#string

Ratnam M

http://www.w3.org/2001/XMLSchema#string

Ross JF

http://www.w3.org/2001/XMLSchema#string

Wang H

http://www.w3.org/2001/XMLSchema#string

Wu M

http://www.w3.org/2001/XMLSchema#string

P2860

Complementary DNA for the folate binding protein correctly predicts anchoring to the membrane by glycosyl-phosphatidylinositol

Identification of a novel folate receptor, a truncated receptor, and receptor type beta in hematopoietic cells: cDNA cloning, expression, immunoreactivity, and tissue specificity

Homologous membrane folate binding proteins in human placenta: cloning and sequence of a cDNA

Preferred sites of glycosylphosphatidylinositol modification in folate receptors and constraints in the primary structure of the hydrophobic portion of the signal

Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications.

Proteolysis of the carboxyl-terminal GPI signal independent of GPI modification as a mechanism for selective protein secretion.

Folate receptor type gamma is primarily a secretory protein due to lack of an efficient signal for glycosylphosphatidylinositol modification: protein characterization and cell type specificity.

Bispecific antibody targeted T cell therapy of ovarian cancer: clinical results and future directions.

Clustering of GPI-anchored folate receptor independent of both cross-linking and association with caveolin.

A flow cytometric assay of CD34-positive cell populations in the bone marrow.

P304

348-357

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/(SICI)1097-0142(19990115)85:2<348::AID-CNCR12>3.0.CO;2-4

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P577

1999-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10023702

http://www.w3.org/2001/XMLSchema#string

P921